Susceptibility of clinical strains of herpes simplex virus to three nucleoside analogues

The susceptibility of clinical isolates of herpes simplex virus 1 (HSV1) (58 strains) and 2 (HSV2) (17 strains) from the Centre Hospitalier et Universitaire de Nancy to three nucleoside analogues was compared by the dye uptake method. As expected, all strains of HSV2 were resistant to brovavir or so...

Full description

Saved in:

Bibliographic Details
Published in:	Chemotherapy (Basel) Vol. 46; no. 3; p. 195
Main Authors:	Edert, D Y, Finance, C M, Le Faou, A E
Format:	Journal Article
Language:	English
Published:	Switzerland 01-05-2000
Subjects:	Acyclovir - analogs & derivatives Acyclovir - pharmacology Antiviral Agents - pharmacology Arabinofuranosyluracil - analogs & derivatives Arabinofuranosyluracil - pharmacology Drug Resistance, Microbial Herpes Simplex - virology Inhibitory Concentration 50 Simplexvirus - drug effects
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	The susceptibility of clinical isolates of herpes simplex virus 1 (HSV1) (58 strains) and 2 (HSV2) (17 strains) from the Centre Hospitalier et Universitaire de Nancy to three nucleoside analogues was compared by the dye uptake method. As expected, all strains of HSV2 were resistant to brovavir or sorivudine. Aciclovir and penciclovir activities were comparable; 2 strains of HSV1 were resistant to these two compounds. Four strains isolated from immunocompromised patients gave different results with brovavir as compared to aciclovir; resistance to aciclovir (1 strain of HSV1) did not correlate with resistance to brovavir (3 strains of HSV1). Following up antiviral susceptibility is of interest for the detection of resistant strains in immunocompromised patients receiving prophylactic aciclovir.
ISSN:	0009-3157
DOI:	10.1159/000007278